TCM
REPL icon

Tekla Capital Management’s Replimune Group REPL Stock Holding History

Tekla Capital Management’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-219,060
Closed -$8.42M – 191
2021
Q2 		$8.42M Hold
219,060
– – 0.27% 93
2021
Q1 		$6.68M Buy
+219,060
New +$8.2M 0.23% 101

Other funds holding REPL

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

Tekla Capital Management's REPL Position: Q3 2021 in Review

Tekla Capital Management sold out of Replimune Group (REPL) in Q3 2021, closing a stake of 219,060 shares — an estimated $8.42M sold.

Tekla Capital Management first reported a position in REPL in Q1 2021 and held it in 2 quarters. The position peaked at $8.42M in Q2 2021. 101 funds tracked by Wall St. Rank hold REPL as of Q3 2021.

  • Tekla Capital Management reported no remaining Replimune Group position as of Q3 2021 after selling out during the quarter.
  • Tekla Capital Management sold 219,060 Replimune Group shares in Q3 2021, an estimated $8.42M.
  • Tekla Capital Management first reported a position in Replimune Group in Q1 2021 and held it in 2 quarters.
  • Tekla Capital Management's Replimune Group position peaked at $8.42M in Q2 2021.
  • 101 funds tracked by Wall St. Rank held Replimune Group as of Q3 2021.

Based on Tekla Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.